85Q.F TRELLUS HEALTH LS -0006

Healthcare Health Care Technology Frankfurt Exchange
0.0005 EUR
Close of Nov 11, 2026
0.0005 0.0175
Market cap
EUR 215K
P/E
-
P/B
0.03x
ROE
-66.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2024.

Is 85Q.F undervalued?

Graham number

The Graham number of TRELLUS HEALTH LS -0006 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TRELLUS HEALTH LS -0006 fundamental analysis

No fundamental analysis for TRELLUS HEALTH LS -0006 yet.

TRELLUS HEALTH LS -0006 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TRELLUS HEALTH LS -0006

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.

Full company profile